Long non-coding RNA PVT1 is associated with tumor progression and predicts recurrence in hepatocellular carcinoma patients.
about
Long Non-Coding RNAs As Potential Novel Prognostic Biomarkers in Colorectal CancerLong noncoding RNAs in hepatocellular carcinoma: Novel insights into their mechanismLong Noncoding RNAs in Digestive System Malignancies: A Novel Class of Cancer Biomarkers and Therapeutic Targets?Long noncoding RNA expression profiles in sub-lethal heat-treated hepatoma carcinoma cells.The lncRNA PVT1 Contributes to the Cervical Cancer Phenotype and Associates with Poor Patient Prognosis.Tetracycline-inducible shRNA targeting long non-coding RNA PVT1 inhibits cell growth and induces apoptosis in bladder cancer cellsThe long noncoding RNAs PVT1 and uc002mbe.2 in sera provide a new supplementary method for hepatocellular carcinoma diagnosis.Meta-analysis of the prognostic value of abnormally expressed lncRNAs in hepatocellular carcinoma.LncRNA PVT1 overexpression is a poor prognostic biomarker and regulates migration and invasion in small cell lung cancer.Global Prioritizing Disease Candidate lncRNAs via a Multi-level Composite Network.Long non-coding RNA PVT1 activates hepatic stellate cells through competitively binding microRNA-152.Long Noncoding RNA PVT1 as a Novel Diagnostic Biomarker and Therapeutic Target for Melanoma.Kanglaite inhibits the expression of drug resistance genes through suppressing PVT1 in cisplatin-resistant gastric cancer cells.LncRNA PVT1 regulates prostate cancer cell growth by inducing the methylation of miR-146a.Long Noncoding RNAs Act as Novel Biomarkers for Hepatocellular Carcinoma: Progress and Prospects.lncRNAs as prognostic molecular biomarkers in hepatocellular carcinoma: a systematic review and meta-analysis.New Insights into the Epigenetics of Hepatocellular Carcinoma.Long non-coding RNA PVT1 promotes osteosarcoma development by acting as a molecular sponge to regulate miR-195.Comprehensive analysis of long non-coding RNA PVT1 gene interaction regulatory network in hepatocellular carcinoma using gene microarray and bioinformatics.LncRNA PVT1 as an effective biomarker for cancer diagnosis and detection based on transcriptome data and meta-analysis.A comprehensive genome-wide analysis of long noncoding RNA expression profile in hepatocellular carcinoma.LncRNA-SVUGP2 suppresses progression of hepatocellular carcinoma.lncRNAs PVT1 and HAR1A are prognosis biomarkers and indicate therapy outcome for diffuse glioma patients.Long Noncoding RNAs as a Key Player in Hepatocellular Carcinoma.Prognostic value of long non-coding RNA PVT1 as a novel biomarker in various cancers: a meta-analysis.TPGLDA: Novel prediction of associations between lncRNAs and diseases via lncRNA-disease-gene tripartite graph.Long noncoding RNA miR503HG, a prognostic indicator, inhibits tumor metastasis by regulating the HNRNPA2B1/NF-κB pathway in hepatocellular carcinoma.lncRNA CCAT1 promotes cell proliferation, migration, and invasion by down-regulation of miR-143 in FTC-133 thyroid carcinoma cell line.Long noncoding RNA PVT1 modulates hepatocellular carcinoma cell proliferation and apoptosis by recruiting EZH2.Pathological bases and clinical impact of long noncoding RNAs in prostate cancer: a new budding starLncRNA PVT1 promotes malignant progression in squamous cell carcinoma of the head and neckLong Non-coding RNA PVT1 Promotes Cell Proliferation and Migration by Silencing ANGPTL4 Expression in CholangiocarcinomalncRNA PVT1 identified as an independent biomarker for prognosis surveillance of solid tumors based on transcriptome data and meta-analysisDownregulation of lncRNA PVT1 expression inhibits proliferation and migration by regulating p38 expression in prostate cancer
P2860
Q26752457-44A1ED6B-2C83-45FC-BBF5-5D31CDEC09DAQ26775818-236538E7-92FB-4AC4-B72E-EC594F4D24FBQ28088454-9A152166-16B9-431C-9947-845E61AD6996Q33922769-82EBD94C-E81C-4BC6-85D9-15309A722B8CQ36032514-63CADC97-F092-42C9-B8DD-0AF4059ECB8FQ36562321-DB501E02-E92D-482B-8480-006E8E52B4F8Q37165105-0E841D27-D82A-42AB-9460-6D303915A9DFQ37197517-527A0181-3308-418A-BC89-F076BD5DDA85Q37448230-B7038691-B6A6-4EFE-90F7-028C38BCD9C6Q37554525-9FF0162A-0612-4AA0-BE8B-10E26FE0E217Q37665189-EB302257-75DD-4318-B84D-B13B0C1BB541Q38713402-54B4A95E-EDBE-4874-8DE0-F7A9780D1F27Q41113421-27C53990-EC3E-47DD-A0B4-D3C985989D6EQ41163263-660C6108-350A-458E-AC65-CFF263D2B2F5Q41408442-98BFE09B-E0F7-4C2E-9D41-81754E7838B9Q41708847-843FD551-045F-42CC-B165-F2C74D967F16Q41990459-6E66699D-9915-4628-A577-B3870B73D0A6Q42316811-E5DA15F5-BE39-454F-B373-2A1B674262B3Q42367909-9CBA3B85-F97C-47B9-AFBE-28781762A421Q42880610-B5DEC172-BB13-4437-951C-9D3EBB7EFEF2Q47156979-8FC24221-FC3D-4BD2-802E-2CB25E035E26Q47261037-808EE848-8AEA-46F2-969C-7E885B6FB351Q47262117-B27ED9A7-5DB2-4F58-9929-67F7BD398048Q47393672-C2536B20-C8A6-40F4-8483-B508DD6CB498Q49210529-D2E81E89-2CD0-42AD-B933-D002702AE6A0Q49307799-16D6B72B-06A9-4A19-B884-0FB00C2C4A2CQ55073980-614B8F23-9A2A-4207-A876-7958B58C9C21Q55470742-A480840F-683C-40C7-B7F7-98E852CBF8EBQ55664343-E3211A1B-8BBC-436B-B915-3E566976E3BEQ57109348-EC6B2C84-9263-4768-B847-45F0E27F985CQ57493784-B4A420F7-A919-4D8C-A726-259475C9E306Q58577267-3413AB3C-A380-48A4-BFE4-41BD0E8EFEB5Q58773738-DB71EAAD-0EF9-4F0B-81AE-D2890EAD5A05Q58779753-D2627AE5-A62F-43B5-8254-DB923220964B
P2860
Long non-coding RNA PVT1 is associated with tumor progression and predicts recurrence in hepatocellular carcinoma patients.
description
2014 nî lūn-bûn
@nan
2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Long non-coding RNA PVT1 is as ...... tocellular carcinoma patients.
@ast
Long non-coding RNA PVT1 is as ...... tocellular carcinoma patients.
@en
Long non-coding RNA PVT1 is as ...... tocellular carcinoma patients.
@nl
type
label
Long non-coding RNA PVT1 is as ...... tocellular carcinoma patients.
@ast
Long non-coding RNA PVT1 is as ...... tocellular carcinoma patients.
@en
Long non-coding RNA PVT1 is as ...... tocellular carcinoma patients.
@nl
prefLabel
Long non-coding RNA PVT1 is as ...... tocellular carcinoma patients.
@ast
Long non-coding RNA PVT1 is as ...... tocellular carcinoma patients.
@en
Long non-coding RNA PVT1 is as ...... tocellular carcinoma patients.
@nl
P2093
P2860
P356
P1433
P1476
Long non-coding RNA PVT1 is as ...... tocellular carcinoma patients.
@en
P2093
Chaofeng Ding
Chengli DU
Chuanhui Peng
Haiyang Xie
Shaobing Cheng
Shusen Zheng
P2860
P304
P356
10.3892/OL.2014.2730
P577
2014-11-24T00:00:00Z